Nobel Biocare (NVST): Rasio kapitalisasi pasar marang pendapatan

Simbol lan logo merek Envista Holdings Corp (NVST)

The market expects Envista Holdings (NVST) under new management to increase margins, as evidenced by fluctuations in the P/S multiple, where the parameter value is 1.40. Global equipment exports are constrained by geopolitics and disruptions in Asia. Consumables ensure revenue stability, although demand for implants remains dependent on economic conditions. This chart's price action helps balance the risks of a drawdown against the potential for business value growth.

Rasio rega marang pendapatan: Envista (NVST) kanggo 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan Envista (NVST)

Ringkesan analitik perusahaan:Envista Holdings Corporation
Produk seri envistaco.com

Stable demand for Envista Holdings (NVST) dental equipment, regardless of geopolitics, makes the company's revenue a predictable foundation for valuation. By analyzing price-to-sales dynamics, an investor determines the market value of a single dollar of sales, which helps identify if the asset is overbought relative to its actual income and avoids investing in a speculative bubble during an anomalous surge in the multiple.

Pesaing Envista Holdings

Kapitalisasi marang volume dodolan ISRG|Danaher Corporation - Kapitalisasi marang pendapatan|Multiplikator P/S Becton Dickinson & Company BDX|STE - Rasio rega marang pendapatan|West Pharmaceutical Services (WST) - Kapitalisasi marang pendapatan|BAX: Multiplikator P/S|Kapitalisasi marang pendapatan Masimo|STVN (stevanatogroup.com) - Multiplikator P/S|Rasio kapitalisasi marang pendapatan TFX (Teleflex Incorporated)|Rasio rega marang pendapatan Merit Medical (MMSI)|ICU Medical - Rasio kapitalisasi marang pendapatan|DENTSPLY SIRONA Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan LMAT (LeMaitre Vascular Inc)|ATRC - Rasio rega marang pendapatan|Koefisien rega marang pendapatan STAAR Surgical Co STAA|NAGE: Multiplikator P/S|Rasio rega marang dodolan ZIMV (ZimVie Inc.)|Rasio rega marang pendapatan AngioDynamics Corp|Rega marang dodolan Cerus Corp. CERS|Rasio rega marang pendapatan Teknova (TKNO)|Monogram Orthopedics Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan Sharps Technology, Inc. STSS|Multiplikator P/S InfuSystem Holdings INFU|UTMD: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan KRMD (KORU Medical)|NYXH: Multiplikator P/S|MBOT (Microbot Medical, Inc) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan PDEX|ZTEK: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S ELUT|Milestone Scientific Inc. - Rasio kapitalisasi marang pendapatan|Rasio rega marang pendapatan NEXGEL, Inc. NXGL|Retractable Tech - Rasio rega marang pendapatan|harvardbioscience.com - Multiplikator P/S|FEMY (Femasys Inc.) - Rasio kapitalisasi marang pendapatan|MHUA: Multiplikator P/S|Predictive Oncology Corp - Rasio kapitalisasi pasar marang pendapatan|CJMB (Callan JMB) - Multiplikator P/S|Rega marang dodolan Atrion Corporation Inc. ATRI|Multiplikator P/S NURO